Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)May 31, 2025 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.17%7.59B | 11.44%7.58B | 13.59%2.57B | 16.33%1.66B | 18.85%2.05B | -6.25%1.31B | 5.50%6.8B | 7.90%2.26B | 5.78%1.43B | 4.92%1.72B |
| Cost of revenue | 4.15%4.63B | 17.70%4.44B | 4.94%1.33B | 36.02%1.14B | 30.58%1.18B | 3.44%788.62M | 1.77%3.78B | 4.52%1.27B | 13.34%840.7M | -6.62%905.11M |
| Gross profit | -5.47%2.96B | 3.62%3.13B | 24.64%1.24B | -11.90%516.49M | 5.85%863.63M | -17.98%516.69M | 10.56%3.03B | 12.55%992.98M | -3.46%586.24M | 21.60%815.93M |
| Operating expense | -2.41%1.96B | 11.49%2.01B | 7.11%552.76M | 18.52%490.56M | 4.16%444.16M | 17.04%522.07M | 2.98%1.8B | -0.64%516.06M | 2.76%413.89M | 5.10%426.44M |
| Operating profit | -10.92%1B | -7.99%1.12B | 43.61%684.93M | -84.95%25.93M | 7.70%419.47M | -102.92%-5.38M | 24.01%1.22B | 31.43%476.93M | -15.72%172.34M | 46.85%389.49M |
| Net non-operating interest income (expenses) | -493.79%-14.91M | -275.84%-2.51M | -964.20%-3.5M | -6.69%739K | 404.26%237K | -92.93%13K | 177.95%1.43M | -82.33%405K | 122.98%792K | 115.77%47K |
| Non-operating interest income | 64.00%5.14M | 37.85%3.14M | 111.22%1.32M | 19.31%766K | 21.71%740K | -22.19%312K | 1,143.17%2.28M | 890.48%624K | 1,589.47%642K | 1,996.55%608K |
| Non-operating interest expense | 255.11%20.05M | 566.71%5.65M | 2,100.00%4.82M | 118.00%27K | -10.34%503K | 37.79%299K | -57.97%847K | 109.83%219K | -104.30%-150K | 71.56%561K |
| Net investment income | -71.68%34.43M | 68.05%121.56M | 401.27%18.2M | 147.40%55.79M | 45.12%-6.79M | -7.11%54.37M | -25.72%72.34M | -92.90%3.63M | 16.11%22.55M | -195.00%-12.37M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 24,957.78%78.93M | 78.93M | 102.12%315K | 0 | 0 | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 2,419.92%47.63M | 94.65%-2.05M | -54.48%-2.05M | 0 | -95,897.50%-38.4M | -5,437.50%-1.33M | -218,137.50%-34.92M | |||
| Less:Other special charges | -2,419.92%-47.63M | -94.65%2.05M | ---- | ---- | ---- | ---- | 95,897.50%38.4M | 5,437.50%1.33M | --34.92M | ---- |
| Other non-operating income (expenses) | 76.51%22.35M | 47.46%12.66M | 168.49%4.31M | 87.80%2.43M | 57.70%2.73M | -19.33%3.19M | 60.58%8.59M | 191.30%1.61M | -31.19%1.3M | 18.36%1.73M |
| Income before tax | -18.15%1.09B | 5.26%1.33B | 62.25%780.81M | -47.62%84.89M | 10.23%415.64M | -78.83%52.2M | 18.19%1.27B | 20.43%481.24M | -27.11%162.06M | 34.94%377.05M |
| Income tax | -22.09%304.53M | -2.35%390.88M | 60.26%241.88M | -133.60%-16.92M | 11.56%131.75M | -57.77%34.17M | 5.50%400.27M | 11.17%150.93M | -32.18%50.34M | 15.30%118.1M |
| Net income | -16.51%787.05M | 8.77%942.67M | 63.16%538.94M | -8.87%101.81M | 9.63%283.89M | -89.11%18.03M | 25.15%866.63M | 25.20%330.31M | -24.57%111.72M | 46.31%258.96M |
| Net income continuous operations | -16.51%787.05M | 8.77%942.67M | 63.16%538.94M | -8.87%101.81M | 9.63%283.89M | -89.11%18.04M | 25.15%866.64M | 25.20%330.31M | -24.57%111.72M | 46.31%258.96M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | ||||||
| Net income attributable to the company | -16.51%787.05M | 8.77%942.67M | 63.16%538.94M | -8.87%101.81M | 9.63%283.89M | -89.11%18.03M | 25.15%866.63M | 25.20%330.31M | -24.57%111.72M | 46.31%258.96M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -16.51%787.05M | 8.77%942.67M | 63.16%538.94M | -8.87%101.81M | 9.63%283.89M | -89.11%18.03M | 25.15%866.63M | 25.20%330.31M | -24.57%111.72M | 46.31%258.96M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -15.79%35.94 | 6.42%42.68 | 60.49%24.45 | -11.35%4.61 | 6.84%12.805 | -89.39%0.815 | 24.63%40.105 | 24.37%15.235 | -24.31%5.2 | 45.71%11.985 |
| Diluted earnings per share | -15.79%35.94 | 6.42%42.68 | 64.77%24.45 | -6.96%4.61 | 11.14%12.805 | -89.39%0.815 | 24.63%40.105 | 27.16%14.8391 | -27.87%4.955 | 40.08%11.5218 |
| Dividend per share | -12.20%9 | 0.00%10.25 | 0.00%10.25 | 0 | 0 | 0 | 70.83%10.25 | 70.83%10.25 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |